116,000+ adults • 45,000+ elevated BP profiles • Noninvasive hemodynamic assessments
Evidence Foundation
A strong foundation from data, peer‑reviewed research, and randomized clinical trials.
Multiple publications in peer‑reviewed international journals
Greater BP reduction without increased medication burden compared with standard care
Reviewed hemodynamic‑guided management evidence from China; supports further U.S. evaluation
Evidence supports feasibility and potential impact in real‑world clinical settings
Why This Matters for the U.S.
The U.S. strategy is focused on targeted bridging and calibration — not rebuilding from scratch. We will validate performance, workflow integration, and clinical utility in U.S. settings through focused studies and partner-aligned pilots.